The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma von Stebbing, Justin, Powles, Thomas, McPherson, Kirsty, Shamash, Jonathan, Wells, Paula, Sheaff, Michael T, Slater, Sarah, Rudd, Robin M, Fennell, Dean, Steele, Jeremy P.C

Volltext

In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion von SZLOSAREK, Peter W, KLABATSA, Astero, FENNELL, Dean A, PALLASKA, Arben, SHEAFF, Michael, SMITH, Paul, CROOK, Tim, GRIMSHAW, Matthew J, STEELE, Jeremy P, RUDD, Robin M, BALKWILL, Frances R

Volltext

Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers von Beddowes, Emma, Spicer, James, Chan, Pui Ying, Khadeir, Ramsay, Corbacho, Javier Garcia, Repana, Dimitra, Steele, Jeremy P, Schmid, Peter, Szyszko, Teresa, Cook, Gary, Diaz, Monica, Feng, Xiaoxing, Johnston, Amanda, Thomson, Jim, Sheaff, Michael, Wu, Bor-Wen, Bomalaski, John, Pacey, Simon, Szlosarek, Peter W

Volltext

Efficacy and safety of first‐ or second‐line irinotecan, cisplatin, and mitomycin in mesothelioma von Fennell, Dean A., Steele, Jeremy P.C., Shamash, Jonathan, Evans, Marie T., Wells, Paula, Sheaff, Michael T., Rudd, Robin M., Stebbing, Justin

Volltext

Phase II Study of Vinorelbine in Patients With Malignant Pleural Mesothelioma von STEELE, Jeremy P. C, SHAMASH, Jonathan, EVANS, Marie T, GOWER, Nicole H, TISCHKOWITZ, Marc D, RUDD, Robin M

Volltext

Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer von Fennell, Dean A., Steele, Jeremy P.C., Shamash, Jonathan, Slater, Sarah E., Sheaff, Michael T., Wells, Paula, Rudd, Robin M., Stebbing, Justin

Volltext

Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma von Fennell, Dean A., C. Steele, Jeremy P., Shamash, Jonathan, Sheaff, Michael T., Evans, Marie T., Goonewardene, Tyronne I, Nystrom, Maria L., Gower, N.H., Rudd, Robin M.

Volltext

Prognostic factors in mesothelioma von Steele, Jeremy P.C., Klabatsa, Astero, Fennell, Dean A., Palläska, Arben, Sheaff, Mike T., Evans, Marie T., Shamash, Jonathan, Rudd, Robin M.

Volltext

Prognostic factors in mesothelioma von Steele, Jeremy P.C.

Volltext

Upregulation of amphiregulin on CD14++CD16- (classical) monocytes in non-small cell lung cancer von McCarthy, Fiona Margaret, Candido, Juliana, Rudd, Robin, Steele, Jeremy P. C., Balkwill, Frances

Volltext

Phase 1 dose-expansion study of pegylated arginine deiminase, cisplatin, and pemetrexed in patients with argininosuccinate synthetase 1 (ASS1)–deficient non-squamous non-small cell... von Wimalasingham, Akhila Ganeshi, Phillips, Melissa Mary, Lim, Louise, Rashid, Sukaina, Hall, Peter Edward, Khadeir, Ramsay, Steele, Jeremy P. C., Conibear, John, Feng, Xiaoxing, Ellis, Stephen, Chan, Pui Ying, Thomson, Jim, Johnston, Amanda L., Bomalaski, John S., Pacey, Simon, Sheaff, Michael, Szlosarek, Peter Wojciech

Volltext

Testicular cancer: perils of very late presentation von Steele, Jeremy PC, Oliver, R Timothy D

Volltext

Expansion study of ADI-PEG 20, pemetrexed and cisplatin in patients with ASS1-deficient malignant pleural mesothelioma (TRAP) von Phillips, Melissa, Szyszko, Teresa, Hall, Peter, Cook, Gary J. R., Khadeir, Ramsay, Steele, Jeremy P. C., Spicer, James F., Feng, Xiaoxing, Hategan, Mirela, Rashid, Sukaina, Johnston, Amanda, Bomalaski, John S., Shamash, Jonathan, Pacey, Simon, Sheaff, Michael, Szlosarek, Peter Wojciech

Volltext

ATOMIC-Meso: A randomized phase 2/3 trial of ADI-PEG20 or placebo with pemetrexed and cisplatin in patients with argininosuccinate synthetase 1-deficient non-epithelioid mesothelio... von Szlosarek, Peter Wojciech, Baas, Paul, Ceresoli, Giovanni Luca, Fennell, Dean Anthony, Gilligan, David, Johnston, Amanda, Lee, Phuong, Mansfield, Aaron Scott, Nolan, Luke, Nowak, Anna K., Steele, Jeremy P. C., Taylor, Paul, Tsao, Anne S., Zauderer, Marjorie Glass, Bomalaski, John S.

Volltext

18-FLT-PET/CT as an imaging biomarker in patients with ASS1-deficient thoracic cancers treated with ADI-PEG20, pemetrexed and cisplatin von Szlosarek, Peter Wojciech, Szyszko, Teresa, Pacey, Simon, Spicer, James F., Phillips, Melissa, Steele, Jeremy P. C., Barba, Adalberto, Diaz, Monica, Johnston, Amanda, Wu, Bor-Wen, Bomalaski, John S., Cook, Gary J. R.

Volltext

Low-dose continuous chemotherapy for metastatic melanoma: a phase II trial von Nystrom, Maria L, Steele, Jeremy P, Shamash, Jonathan, Neville, Frances, Oliver, R Timothy

Volltext

Testicular carcinoma: postmortem diagnosis after a car accident von STEELE, Jeremy P. C, OLIVER, R. Timothy D, DE BOER, H. D, HAERKENS, M. H. T. M, VAN DER STAPPEN, W, VAN INGEN, G, WOBBES, T

Volltext

Liposomal vincristine for the treatment of human acute lymphoblastic leukaemia in severe combined immunodeficient (SCID) mice von MILLAR, J. L, MILLAR, B. C, POWLES, R. L, STEELE, J. P. C, CLUTTERBUCK, R. D, MITCHELL, P. L. R, COX, G, FORSSEN, E, CATOVSKY, D

Volltext

Late Effects of Small-Cell Lung Cancer Treatment von Coutroubis, Daphne M., Steele, Jeremy P. C.

Volltext

Prognostic Factors in Mesothelioma von Steele, Jeremy P. C., Fennell, Dean A.

Volltext